Vipshop Not Done De...
Health Care: Drugs
NPS Pharmaceuticals Inc (NPSP: NASDAQ)
$14.53 0.42 | 2.98%
05/21/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| NPSP | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 78.72 | 103.61 | 97.51 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 28.50 | 0.55 | 0.16 |
| Net Income | 0.05 | 0.00 | |
| EPS | -0.41 | 0.00 |
Earnings for NPSP:
| EBITDA | -1.00 |
| REVENUE | 130.64M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.08 | $-0.05 | $-0.22 | $0.35 |
| Number of Analysts | 6 | 6 | 8 | 7 |
| High Estimate | $-0.05 | $-0.01 | $-0.09 | $0.71 |
| Low Estimate | $-0.13 | $-0.08 | $-0.30 | $-0.21 |
| Prior Year | $0.08 | $-0.04 | $-0.22 | $-0.22 |
| Growth Rate (Year over Year) | -200.00% | -20.83% | 2.27% | 262.79% |
Portfolios with NPSP
- Portfolio NameUser Type
- UserMy Watch List
- UserJaq Le Blanc 09/30
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Under-$10 Moving Hig...
- Userchinahound2
- ContributorBreakout Stocks Of The Week...
- Usersalvatore Portfolio 1
- UserRocket Stocks for the week ...
Latest NPSP Headlines from TheStreet
- NPS Pharmaceuticals Inc Stock Upgraded (NPSP) 05.14.13 | 05:05 am
- Cramer's Top Stock Picks: WM VRTX SRPT NPSP DR 04.03.13 | 06:04 am
- Cramer's 'Mad Money' Recap: The Winning Formula 04.02.13 | 08:04 pm
- Mad Money Uncovered: Orphan Drug Stocks
03.20.13 | 12:03 pm - Cramer's Top Stock Picks: HTZ NPSP GLD 03.20.13 | 06:03 am
- Cramer's 'Mad Money' Recap: Be an Informed Skeptic 03.19.13 | 08:03 pm
- Tuesday Trend Continues: Morning Movers 03.19.13 | 10:03 am
- Morning Briefing: 10 Things You Should Know 03.19.13 | 05:03 am
- NPS Pharma Buys Back Worldwide Rights To Short Bowel Syndrome Drug 03.19.13 | 02:03 am
- Biotech Stock Mailbag: Peregrine, Arena, Dendreon, NPS Pharma 01.18.13 | 08:01 am
Press Releases for NPSP
- NPS Pharmaceuticals And Takeda Revise Agreements And NPS Re-Gains Full Worldwide Rights To Teduglutide And Recombinant Human Parathyroid Hormone 1-84 - Business Wire 03.19.13 | 02:03 am
- NPS Pharmaceuticals To Present At Barclays Capital Global Healthcare Conference - Business Wire 03.05.13 | 08:03 am
- NPS Pharmaceuticals Observes Rare Disease Day 2013 And Celebrates 30th Anniversary Of National Organization For Rare Disorders - Business Wire 02.28.13 | 08:02 am
- NPS Pharmaceuticals Reports 2012 Financial Results And 2013 Guidance - Business Wire 02.21.13 | 04:02 pm
- NPS Pharmaceuticals To Present At RBC Capital Markets Healthcare Conference - Business Wire 02.19.13 | 04:02 pm
- NPS Pharmaceuticals To Report 2012 Financial Results - Business Wire 02.13.13 | 08:02 am
- NPS Pharmaceuticals To Present At Upcoming Conferences - Business Wire 02.05.13 | 04:02 pm
- New Peer-reviewed Publication Offers Guidance For Integrating Gattex® (Teduglutide [rDNA Origin]) For Injection Into Management Of Short Bowel Syndrome - Business Wire 01.30.13 | 08:01 am
- NPS Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire 01.03.13 | 08:01 am
- NPS Pharmaceuticals To Host Conference Call To Discuss FDA Approval Of Gattex® (teduglutide [rDNA Origin]) For Injection For The Treatment Of Adult Short Bowel Syndrome - Business Wire 01.02.13 | 08:01 am
Partner Headlines for NPSP
- Current Prime Pharma Entries In Anticipation Of Prime Time Exits - Seeking Alpha 11.06.12 | 09:11 am
- Benzinga Mid-Day Market Update - Benzinga 10.16.12 | 01:10 pm
- 3 Best Biotech Stocks For This Week (Part VI) - Seeking Alpha 10.16.12 | 08:10 am
- NPS Pharmaceuticals: Buy If There Is A Dip - Seeking Alpha 10.14.12 | 08:10 am
- UPDATE: Morgan Stanley Initiates NPS Pharmaceuticals at Overweight on Portfolio Quality - Benzinga 10.04.12 | 01:10 pm
- NPS Pharma Says Gattex Meeting October 16th - Benzinga 08.21.12 | 08:08 am
- 7 High-Growth Small-Cap Stocks With Strong Buy Ratings - Seeking Alpha 07.28.12 | 09:07 am
- Amylin Pharmaceutical POPS 8.9% with 4 Stocks Hitting 52-Week Highs - Wall St. Cheat Sheet 07.03.12 | 10:07 am
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
